Controlling healthcare-associated infections in the NHS.
The prevention and control of healthcare-associated infection (HCAI) is a priority for the NHS. The delivery of national targets for reducing methicillin resistant Staphylococcus aureus bacteraemias and Clostridium difficile infection are supported by enhanced mandatory surveillance through the Health Protection Agency and a Department of Health improvement programme that promotes policies and protocols for enhancing clinical procedures and places infection prevention and control at the centre of clinical and corporate governance. The Health Act 2006 Code of Practice makes such policies and protocols a legal requirement and compliance will be assessed by the Healthcare Commission. Clinicians must recognise their responsibilities for patient safety and take a lead role in ensuring good practice to reduce HCAI.
Duerden
Brian
B
Department of Health, London. brian.duerden@dh.gsi.gov.uk
D003015:Clostridium Infections / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D003428:Cross Infection / Q000517:prevention & control*; D019317:Evidence-Based Medicine; D006801:Humans; D017053:Infection Control / Q000379:methods*; D016106:Methicillin Resistance; D017410:Practice Guidelines as Topic; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D013211:Staphylococcus aureus / Q000187:drug effects / Q000472:pathogenicity; D013222:State Medicine / Q000592:standards; D006113:United Kingdom / Q000453:epidemiology